Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tramadol/Paracetamol add-on in chronic osteoarthritis
NCT01728246Phase 4Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Oct 2007
- Primary completion
- May 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in osteoarthritis (OA) comparing Tramadol/Paracetamol (APAP) with Non-Tramadol/APAP (2 arms). Primary endpoints: Visual Analogue Scale for Pain at 4 weeks, Oswestry Disability Index at 4 weeks and 2 more. Started Oct 2007; status: completed.
02
Drugs
tramadolacetaminophen
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT01728246.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01728246.